Regulus Therapeutics Stock Forecast

Stock Price Forecast

According to 6 professional analysts, the 12-month price target for Regulus Therapeutics stock ranges from a low of $7.00 to a high of $11. The average analyst price target of $8.50 forecasts a 8.42% increase in the stock price over the next year.

Price Target: $8.50 (+8.42%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$8.50	$9.00	$11
Change	-10.71%	+8.42%	+14.80%	+40.31%

Analyst Ratings

The average analyst rating for Regulus Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	3	3	3	3	1	1
Buy	2	2	2	2	2	1
Hold	1	1	1	0	3	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yanan Zhu Wells Fargo	Wells Fargo	Buy → Hold Downgrades $9	Buy → Hold	Downgrades	$9	+14.80%	May 1, 2025
Joseph Schwartz Leerink Partners	Leerink Partners	Buy → Hold Downgrades $7	Buy → Hold	Downgrades	$7	-10.71%	Apr 30, 2025
Catherine Novack Jones Trading	Jones Trading	Strong Buy → Hold Downgrades $8 → $7	Strong Buy → Hold	Downgrades	$8 → $7	-10.71%	Apr 30, 2025
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Strong Buy → Hold Downgrades $28 → $11	Strong Buy → Hold	Downgrades	$28 → $11	+40.31%	Apr 30, 2025
Yanan Zhu Wells Fargo	Wells Fargo	Hold → Buy Upgrades $3 → $6	Hold → Buy	Upgrades	$3 → $6	-23.47%	Mar 27, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.30

from -0.82

EPS Next Year

-1.41

from -1.30

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	10.01M	-	-	-	-	-	-	180.34M
Revenue Growth	46.46%	-	-	-	-	-	-	-
EPS	-4.50	-3.24	-1.86	-1.58	-0.82	-1.30	-1.41	-1.15
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	7	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	185.6M
Avg	n/a	n/a	180.3M
Low	n/a	n/a	173.3M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.99	-0.71	0.60
Avg	-1.30	-1.41	-1.15
Low	-2.19	-2.77	-2.77

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.